Completed Clinical Trials

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

By April 24, 2017 No Comments

Condition

Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma

Estimated Enrollment: 55

Age Group: Child, Adult, Senior

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: NCI-2012-02466|SWOG-S0218|U10CA032102|CDR0000069360

Study First Received: June 6, 2002

Last Updated: January 23, 2013

Estimated Primary Completion Date: June 2007

 

Primary Outcome Measures:

Overall survival rate|RECIST response rate|Association between EGFR expression with survival and response

Sponsors and Collaborators:

National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00039182

Leave a Reply

Call Now ButtonCall Now